Logos Global Management LP Aclaris Therapeutics, Inc. Transaction History
Logos Global Management LP
- $775 Million
- Q2 2025
A detailed history of Logos Global Management LP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,850,000 shares of ACRS stock, worth $3.03 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
1,850,000
Previous 2,222,222
16.75%
Holding current value
$3.03 Million
Previous $3.4 Million
22.71%
% of portfolio
0.34%
Previous 0.66%
Shares
5 transactions
Others Institutions Holding ACRS
# of Institutions
98Shares Held
87.6MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$23.4 Million15.31% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15.8 Million0.02% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$14.6 Million2.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$10.9 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.77MShares$7.82 Million0.46% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $109M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...